Maryann Selfe — Investment Strategist & Author

For more than twenty years I worked in private wealth and institutional investing, advising family offices and institutional investors on manager selection, portfolio construction and long-term capital allocation across public and private markets.

During that time I helped oversee more than CHF 5 billion in investment mandates and advised on over CHF 700 million in client assets.

But over time, a pattern became impossible to ignore.

Scientific innovation was accelerating across women's health, precision medicine and longevity. Demographic change was reshaping demand. Capital was beginning to notice. Yet the infrastructure institutional investors rely on to evaluate, access and allocate capital to emerging healthcare markets was still missing.

The opportunity was growing faster than the systems designed to finance it.

That observation became the foundation of my work.

Today, I write, speak and advise at the intersection of healthcare innovation, capital allocation and market development. Through The Billion Dollar Blindspot, FemmeHealth Alliance and Calabar Capital, I am building the market intelligence, strategic relationships and investment infrastructure required for this emerging healthcare sector to mature into an institutional investment category.

My conviction remains simple: scientific innovation alone does not create an institutional investment category. Markets mature when specialist expertise, investment infrastructure and capital evolve together.

That is the perspective I bring to every conversation — with investors, specialist managers, healthcare organisations and institutions navigating the future of healthcare.